Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 16:15:1467144.
doi: 10.3389/fpsyt.2024.1467144. eCollection 2024.

Consumption patterns before and during the COVID-19 pandemic among patients admitted to inpatient drug detoxification treatment: Results of two cross-sectional surveys from 2018 and 2021

Patrik Roser  1   2 , Michael Specka  1 , Udo Bonnet  1   3 , Thomas Kuhlmann  4 , Stefan Kühnhold  5 , Renate Steinert  6 , Benita Zeiske  7 , Daniel Deimel  1   8 , Norbert Scherbaum  1
Affiliations

Consumption patterns before and during the COVID-19 pandemic among patients admitted to inpatient drug detoxification treatment: Results of two cross-sectional surveys from 2018 and 2021

Patrik Roser et al. Front Psychiatry. .

Abstract

Background: The lockdown measures during the SARS-CoV-2 pandemic could have influenced drug consumption patterns of persons with drug use disorder, especially due to a reduced availability of drugs, an increased consumption of sedating substances as a coping strategy, or a shift to novel psychotropic substances (NPS) associated with an increased drug buying in the internet. In this study, the consumption patterns of people mainly with opioid use disorder entering inpatient drug detoxification treatment were investigated in the same hospitals with the same methods before and during the pandemic.

Methods: At admission, patients were interviewed regarding their consumption patterns using the EuropASI questionnaire. In addition, changes in the routes of drug acquisition were assessed.

Results: In five hospitals in Western Germany, 213 (2021) and 175 persons (2018) were recruited. Sociodemographic data were similar in both cohorts (mean age around 40 years, mainly male, about 50% with migrant background, high unemployment rate). Rates of use of various drugs during the last 30 days were also similar. Differences were detected for gabapentinoids and opioid analgesics (increase >5%) as well as for cannabis (decrease >5%). Current use of NPS was low in both surveys. Only a minority of patients had experiences with drug acquisition in the internet.

Discussion: The pandemic had only a minor influence on consumption patterns and routes of drug acquisition in this sample. It remains to be seen whether the increased use of gabapentinoids and opioid analgesics will continue despite the end of the pandemic.

Keywords: COVID-19; consumption pattern; gabapentinoids; novel psychotropic substances; opioid use disorder; route of acquisition.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Current use of drugs (last 30 days prior to admission) before and during the COVID-19 pandemic.
Figure 2
Figure 2
Lifetime use of different novel psychotropic substances, new synthetic opioids, medically prescribed cannabis and opioid analgesics before and during the COVID-19 pandemic.
Figure 3
Figure 3
Current use of different novel psychotropic substances, new synthetic opioids, medically prescribed cannabis and opioid analgesics before and during the COVID-19 pandemic.
Figure 4
Figure 4
Routes of drug acquisition before and during the COVID-19 pandemic.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. World Health Organization . WHO Director-General’s opening remarks at the media briefing on COVID-19 (2020). Available online at: https://www.who.int/director-general/speeches/detail/who-director-genera... (Accessed April 1, 2023).
    1. Federal Government of the Federal Republic of Germany . Agreement between the Federal Government and the Federal States: Guidelines for the Control of the Corona Epidemic in Germany (2020). Available online at: https://www.bundesregierung.de/breg-de/themen/coronavirus/leitlinien-zum... (Accessed April 1, 2023).
    1. Farhoudian A, Baldacchino A, Clark N, Gerra G, Ekhtiari H, Dom G, et al. . COVID-19 and substance use disorders: Recommendations for a comprehensive health care response. Basic Clin Neurosci. (2020) 11:133–50. doi: 10.32598/bcn.11.covid19.1 - DOI - PMC - PubMed
    1. Kilian C, O’Donnell A, Potapova N, López-Pelayo H, Schulte B, Miquel L, et al. . Changes in alcohol use during the COVID-19 pandemic in Europe: A meta-analysis of observational studies. Drug Alcohol Rev. (2022) 41:918–31. doi: 10.1111/dar.13446 - DOI - PMC - PubMed
    1. Schmidt RA, Genois R, Jin J, Vigo D, Rehm J, Rush B. The early impact of COVID-19 on the incidence, prevalence, and severity of alcohol use and other drugs: A systematic review. Drug Alcohol Depend. (2021) 228:109065. doi: 10.1016/j.drugalcdep.2021.109065 - DOI - PMC - PubMed

LinkOut - more resources